Newest Monoclonal Antibody Therapy Permitted for Excessive-Threat Sufferers
The Food and Drug Administration on Wednesday approved a monoclonal antibody drug developed by GlaxoSmithKline and Vir as the third treatment of its kind to keep high-risk Covid patients out of the hospital.In laboratory tests, the newly…